As a start-up biotech, Ab Studio aims to support the whole therapeutic antibody R&D field with 1) novel technology platforms on making bispecific, internalization antibodies and catalytic antibody to treat drug resistant cancer and CNS diseases; and 2) high quality antibody discovery, design and engineering services. From 2017 to 2019, Ab Studio has filed three novel technology patent applications, designed and licensed out five bispecific antibodies and successfully completed over 60 partner projects and service projects. We deeply believe in the “quality by design” concept and wish our work can make significant contributions to the whole therapeutic antibody development field.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Platform for Therapeutics
Lead Product in Development:
Trispecific therapeutic antibodies neutralizing SARS-CoV-2, and targeting multiple myeloma
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Three
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
